Curaleaf Holdings, Inc.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Curaleaf Holdings, Inc. operates as a holding company with interest in medical and wellness cannabis operations. It operates through the Cannabis Operations and Non-Cannabis Operations segments. The Cannabis Operations segment includes the production and sale of cannabis via retail and wholesale channels. The Non-Cannabis Operations segment provides professional services including cultivation, processing and retail know-how and back office administration, intellectual property licensing, real estate leasing services and lending facilities to medical and adult-use cannabis licensees under management service agreements. The company was founded on November 13, 2014 and is headquartered in New York, NY.

LONDON--(BUSINESS WIRE)--Curaleaf International (formerly EMMAC Life Sciences Group) (“Curaleaf International”), Europe's largest vertically integrated cannabis company, is pleased to announce it has successfully exported over one metric ton of medical cannabis to BOL Pharma in Israel. Curaleaf International is one of the first companies to export medical cannabis to Israel under the country's new regulatory regime. The initial shipment, comprising two strains of dried flower, was shipped from

Curaleaf International Exports Over a Ton of Medical Cannabis Flower to Israel; One of the First Companies to Do so Under New Regulatory Regime

Green Thumb Industries Inc.

AdvisorShares Pure US Cannabis ETF

Trulieve Cannabis Corp.

Annual retail sales of cannabis in the U.S. will increase to $64 billion by 2030 from $17.2 billion in 2020, one analyst estimates.

U.S. Pot Stocks Are Wealth Builders, Analyst Says. The Stocks Jumped.

They are some of the biggest names in the industry, and they already have presences in the state.

These 3 MSOs Are Ready for Connecticut's New Recreational Marijuana Market

Agrify

Agrify Corporation (NASDAQ:AGFY) has teamed up with Curaleaf Holdings, Inc. (OTCQX:CURLF) to determine the impact of the cultivation environment on the overall health of cannabis plants and harvest yields. Under the deal, the Massachusetts-based company agreed to provide the use of its Agrify Insights software platform for three years to Curaleaf's facility located in the Bay State.

Agrify And Curaleaf Study Impact Of Cannabis Cultivation On Plant Health And Harvest Yields, Curaleaf International Expands

LONDON--(BUSINESS WIRE)--Curaleaf International (formerly EMMAC Life Sciences Group) (“Curaleaf International”), Europe's largest vertically integrated cannabis company, is pleased to announce that Medalchemy, the Group's Good Manufacturing Practice (“GMP”) certified manufacturing site in Alicante, Spain has secured approval from the Spanish Health Authorities (“AEMPS”) to import, manufacture and export medical cannabis flower. Medalchemy now has fully integrated cannabis supply facilities, wit

Curaleaf International Secures Complete GMP Certification of Second EU GMP Facility in Europe

Could These Top Marijuana Stocks Could Hold Future Upside For Investors? The post Best Marijuana Stocks For Your Watchlist In July? 3 Top US Pot Stocks To Check Out appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Best Marijuana Stocks For Your Watchlist In July? 3 Top US Pot Stocks To Check Out

Top Marijuana Stocks To Watch This Month The post Top Marijuana Stocks To Watch To Close Out The Week appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Top Marijuana Stocks To Watch To Close Out The Week

WAKEFIELD, Mass., July 1, 2021 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced that it will report its financial and operating results for the second quarter ended June 30, 2021 after market close on August 9, 2021.

Curaleaf to Report Second Quarter 2021 Financial and Operational Results

As Curaleaf International's subsidiary Adven GmbH seeks to advance its medical cannabis products in Germany, it has teamed up with an Italian pharmaceutical company, Zambon Spa, with whom it will provide medical cannabis treatments for patients, with an initial focus on neurological therapies. Based in London, Curaleaf said Tuesday the first treatment will be launched in Germany in the months to come.

Curaleaf International's Subsidiary Teams Up With Germany's Zambon Spa To Provide Medical Cannabis Treatments

Companies big and small will face the necessary evils of regulations.

This Cannabis Behemoth May Have to Yield Some Revenue to Mom-and-Pop Shops

LONDON, June 29, 2021 /PRNewswire/ -- Curaleaf International (formerly EMMAC Life Sciences Group), Europe's largest vertically integrated cannabis company, is pleased to announce that its wholly owned subsidiary, Adven GmbH ("Adven"), has announced a strategic partnership with Zambon GmbH, the German subsidiary of Zambon Spa, an Italian multinational pharmaceutical company, leading in Parkinson's Disease, severe respiratory diseases and pain. The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies.

Curaleaf International Advances Accessibility of Medical Cannabis Products in Germany with Strategic Partnership

Pot companies may do better dealing with a fairer tax code than navigating a regulatory labyrinth.

Do Cannabis Stocks Need Tax Reform More Than Legalization?

These Top US Marijuana Stocks Could Be Big Gainers In 2021 The post Best Ways To Invest In Top Marijuana Stocks In 2021? 5 Cannabis Stocks For Your Watchlist Next Week appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Best Ways To Invest In Top Marijuana Stocks In 2021? 5 Cannabis Stocks For Your Watchlist Next Week

These Could Be Some Of The Best Cannabis Stocks In The US In 2021 The post Which Top Marijuana Stocks Would You Buy Right Now? 2 With Upside According To Analysts appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Which Top Marijuana Stocks Would You Buy Right Now? 2 With Upside According To Analysts

Opening Marks Company's 107th Retail Location Nationwide Strategic Expansion Will Help Serve the State's Rapidly Growing Cannabis Market WAKEFIELD, Mass., June 24, 2021 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced the opening of Curaleaf Edgewater Park, the Company's second dispensary in New Jersey and 107th dispensary nationwide.

Curaleaf Expands Presence in New Jersey with New Dispensary and Cultivation Facility

Canopy Growth

Nothing is certain, but the prospects are better than they've ever been.

Why Investors Can Be Cautiously Optimistic About Major Cannabis Reform in the U.S.

After Connecticut Gov. Ned Lamont signed an adult-use cannabis bill into law on Tuesday, making it the 18th U.S. state to legalize marijuana, Cantor Fitzgerald's Pablo Zuanic shared his insights on the new market.

Cantor Fitzgerald: Curaleaf And Green Thumb Best Positioned To Thrive In Connecticut's New Cannabis Market

Both of these heavyweights are headed for $1 billion in sales next year, but which one is the better buy overall?

Better Cannabis Stock: Curaleaf vs. Trulieve

WAKEFIELD, Mass., June 22, 2021 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced Boris Jordan, Curaleaf Executive Chairman, will participate in Cantor Fitzgerald's cannabis focused "Weednesday Series" investor fireside chat on June 30, 2021 at 11:00 am ET.

Curaleaf Announces Participation in Cantor Fitzgerald Investor Fireside Chat

Greenlane Holdings

3 Marijuana Stocks To Watch For Better Trading Next Week The post 3 Marijuana Stocks To Watch Before Next Week Monday appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

3 Marijuana Stocks To Watch Before Next Week Monday

Amplify Seymour Cannabis ETF

Amplify Alternative Harvest ETF

Global X Cannabis ETF

AXS Cannabis ETF

Cambria Cannabis ETF

AdvisorShares Vice ETF

AdvisorShares Pure Cannabis ETF 

Emily Paxhia is co-founder and Managing Partner of Poseidon Asset Management, one of the earliest and longest-running funds in the cannabis space. The disappointing political picture around cannabis decriminalization and legalization.

Current State Of Cannabis (Podcast Transcript)

Tilray Brands

Maybe regulation and taxation of cannabis is the best idea after all.

Can Marijuana Stocks Survive Legalization?

Innovative Industrial Properties

Stem, Inc

Our first two Master Classes in cannabis investing with SA authors James Baker and Julian Lin were so successful we're coming back for #3! We discuss why retail cannabis investors are focused too much on near term catalysts and missing the long term picture.

Master Class In Cannabis Investing, Part 3 (Podcast Transcript)

Current State Of Cannabis (Podcast)

They have all been busy with mergers, acquisitions, and expanding their businesses.

3 Cannabis Stocks On Track to Hit $1 Billion in Revenue Next Year

News for Curaleaf Holdings, Inc. Stock (CURLF)